The current financial position of SYNMOSA BIOPHARMA CORP

Total assets of 4114 for Q3 24 is 12.18 B TWD, 0.91% more than the previous Q2 24. And total liabilities increased by 0.03% in Q3 24 to 3.85 B TWD.